We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 18

Patents and Canadian competition laws

  • Gowling Lafleur Henderson LLP
  • -
  • Canada, USA
  • -
  • April 22 2013

In Canada, the Competition Act largely defers to the Patent Act. For example, the Act's abuse of dominance provision (s. 79 Canada's

Dispelling the Myriad gene patent harmonization myth

  • Foley & Lardner LLP
  • -
  • Australia, Canada, European Union, France, Germany, Japan, USA
  • -
  • April 30 2013

In the wake of the Supreme Court oral arguments in the Myriad "gene patent" case, most commentators are predicting that the Court will uphold the

Northern exposure?

  • Gowling Lafleur Henderson LLP
  • -
  • Canada, USA
  • -
  • April 4 2013

Davit Akman and John Norman suggest that a recently commenced investigation into alleged "product switching" and statements by the Interim

Common sense and obviousness: supporting evidence is required

  • Bereskin & Parr LLP
  • -
  • Canada, USA
  • -
  • June 12 2012

Whether enforcing a patent or prosecuting a patent application, obviousness is often the key issue

Determining patentable subject matter in the United States and Canada

  • Bereskin & Parr LLP
  • -
  • Canada, USA
  • -
  • April 10 2012

As reported in our March 21, 2012, Spring Alert, the United States Supreme Court recently held in Prometheus v. Mayo that certain personalized medicine claims were directed to laws of nature and were thus unpatentable despite containing both an administering step and a determining step

The U.S. Prometheus decision and claims to methods of optimizing dosing regimens: Mayo Collaborative Services v. Prometheus Laboratories, Inc., U.S., No. 10-1150

  • Gowling Lafleur Henderson LLP
  • -
  • Canada, USA
  • -
  • April 11 2012

In a decision last month, the U.S. Supreme Court in a 9-0 ruling has held that the method claims of two patents directed to optimizing the dose of a specific drug for treating an autoimmune disease are not patentable because they merely recite laws of nature

Apple’s win could put smartphone competitors in a pinch

  • Norton Rose Canada LLP
  • -
  • Canada, USA
  • -
  • August 30 2012

A jury ruling in Apple’s favour over Samsung in the United States District Court could have a chilling effect on rivals, and leave them scrambling for alternatives to common touch-screen gestures used in consumer electronic devices

US Supreme Court rules on the eligibility of business methods for patenting

  • McCarthy Tétrault LLP
  • -
  • Canada, USA
  • -
  • August 11 2010

Recently, the United States Supreme Court issued its long-awaited judgment in Bilski v Kappos, which deals with important questions surrounding the patentability of business methods and other subject matter, including software and other process-related innovations

Recent developments on the scope of patentable subject matter

  • Cassels Brock & Blackwell LLP
  • -
  • Canada, USA
  • -
  • July 29 2010

Whether or not non-tangible businesses processes, such as digital and internet business processes, are patentable is an issue that has vexed inventors and their advisors for a number of years

U.S. Supreme Court decides case brought by i4i against Microsoft

  • McMillan LLP
  • -
  • Canada, USA
  • -
  • June 13 2011

The case Toronto's i4i brought against Microsoft Inc. can be considered from a number of different perspectives